Hou et al.188 developed a glycopeptide-based PKM2 nano-activator capable of significantly inhibiting tumor proliferation, chemoresistance, and metastasis by inducing the tetramerization of pyruvate kinase muscle isoform 2 (PKM2), a critical enzyme in aerobic glycolysis. Here, PKM is linked to neoplasm.